<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR210.html">Part 210
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 210.3  Definitions.
                            </h3>
                            <p class="depth1"><em>(a)</em> The definitions and interpretations contained in section 201 of  the act shall be applicable to such terms when used in this part and in  parts 211, 225, and 226 of this chapter.</p><p class="depth1"><em>(b)</em> The following definitions of terms apply to this part and to  parts 211, 225, and 226 of this chapter.</p><p class="depth2"><em>(1)</em> Act means the Federal Food, Drug, and Cosmetic Act, as amended  (21 U.S.C. 301 et seq.).</p><p class="depth2"><em>(2)</em> Batch means a specific quantity of a drug or other material that  is intended to have uniform character and quality, within specified  limits, and is produced according to a single manufacturing order during  the same cycle of manufacture.</p><p class="depth2"><em>(3)</em> Component means any ingredient intended for use in the  manufacture of a drug product, including those that may not appear in  such drug product.</p><p class="depth2"><em>(4)</em> Drug product means a finished dosage form, for example, tablet,  capsule, solution, etc., that contains an active drug ingredient  generally, but not necessarily, in association with inactive  ingredients. The term also includes a finished dosage form that does not  contain an active ingredient but is intended to be used as a placebo.</p><p class="depth2"><em>(5)</em> Fiber means any particulate contaminant with a length at least  three times greater than its width.</p><p class="depth2"><em>(6)</em> Nonfiber releasing filter means any filter, which after  appropriate pretreatment such as washing or flushing, will not release  fibers into the component or drug product that is being filtered.</p><p class="depth2"><em>(7)</em> Active ingredient means any component that is intended to  furnish pharmacological activity or other direct effect in the  diagnosis, cure, mitigation, treatment, or prevention of disease, or to  affect the structure or any function of the body of man or other  animals. The term includes those components that may undergo chemical  change in the manufacture of the drug product and be present in the drug  product in a modified form intended to furnish the specified activity or  effect.</p><p class="depth2"><em>(8)</em> Inactive ingredient means any component other than an active  ingredient.</p><p class="depth2"><em>(9)</em> In-process material means any material fabricated, compounded,  blended, or derived by chemical reaction that is   produced for, and used in, the preparation of the drug product.</p><p class="depth2"><em>(10)</em> Lot means a batch, or a specific identified portion of a batch,  having uniform character and quality within specified limits; or, in the  case of a drug product produced by continuous process, it is a specific  identified amount produced in a unit of time or quantity in a manner  that assures its having uniform character and quality within specified  limits.</p><p class="depth2"><em>(11)</em> Lot number, control number, or batch number means any  distinctive combination of letters, numbers, or symbols, or any  combination of them, from which the complete history of the manufacture,  processing, packing, holding, and distribution of a batch or lot of drug  product or other material can be determined.</p><p class="depth2"><em>(12)</em> Manufacture, processing, packing, or holding of a drug product  includes packaging and labeling operations, testing, and quality control  of drug products.</p><p class="depth2"><em>(13)</em> The term medicated feed means any Type B or Type C medicated  feed as defined in Sec. 558.3 of this chapter. The feed contains one or  more drugs as defined in section 201(g) of the act. The manufacture of  medicated feeds is subject to the requirements of part 225 of this  chapter.</p><p class="depth2"><em>(14)</em> The term medicated premix means a Type A medicated article as  defined in Sec. 558.3 of this chapter. The article contains one or more  drugs as defined in section 201(g) of the act. The manufacture of  medicated premixes is subject to the requirements of part 226 of this  chapter.</p><p class="depth2"><em>(15)</em> Quality control unit means any person or organizational element  designated by the firm to be responsible for the duties relating to  quality control.</p><p class="depth2"><em>(16)</em> Strength means:</p><p class="depth3"><em>(i)</em> The concentration of the drug substance (for example, weight/ weight, weight/volume, or unit dose/volume basis), and/or</p><p class="depth3"><em>(ii)</em> The potency, that is, the therapeutic activity of the drug  product as indicated by appropriate laboratory tests or by adequately  developed and controlled clinical data (expressed, for example, in terms  of units by reference to a standard).</p><p class="depth2"><em>(17)</em> Theoretical yield means the quantity that would be produced at  any appropriate phase of manufacture, processing, or packing of a  particular drug product, based upon the quantity of components to be  used, in the absence of any loss or error in actual production.</p><p class="depth2"><em>(18)</em> Actual yield means the quantity that is actually produced at  any appropriate phase of manufacture, processing, or packing of a  particular drug product.</p><p class="depth2"><em>(19)</em> Percentage of theoretical yield means the ratio of the actual  yield (at any appropriate phase of manufacture, processing, or packing  of a particular drug product) to the theoretical yield (at the same  phase), stated as a percentage.</p><p class="depth2"><em>(20)</em> Acceptance criteria means the product specifications and  acceptance/rejection criteria, such as acceptable quality level and  unacceptable quality level, with an associated sampling plan, that are  necessary for making a decision to accept or reject a lot or batch (or  any other convenient subgroups of manufactured units).</p><p class="depth2"><em>(21)</em> Representative sample means a sample that consists of a number  of units that are drawn based on rational criteria such as random  sampling and intended to assure that the sample accurately portrays the  material being sampled.</p><p class="depth2"><em>(22)</em> Gang-printed labeling means labeling derived from a sheet of  material on which more than one item of labeling is printed.  [43 FR 45076, Sept. 29, 1978, as amended at 51 FR 7389, Mar. 3, 1986; 58  FR 41353, Aug. 3, 1993; 73 FR 51931, Sept. 8, 2008; 74 FR 65431, Dec.  10, 2009]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
